N01-CB-23876/CB/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1981	8
1982	2
1983	7
1984	5
1985	4
1986	1
2024	0

1

The impact of pathology on the biologic, diagnostic, prognostic, and therapeutic considerations in breast cancer.

Fisher ER. Fisher ER. Surg Clin North Am. 1984 Dec;64(6):1073-93. doi: 10.1016/s0039-6109(16)43480-8. Surg Clin North Am. 1984. PMID: 6096976 Review.

2

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

Fisher B, Redmond C, Brown A, Wickerham DL, Wolmark N, Allegra J, Escher G, Lippman M, Savlov E, Wittliff J, et al. Fisher B, et al. J Clin Oncol. 1983 Apr;1(4):227-41. doi: 10.1200/JCO.1983.1.4.227. J Clin Oncol. 1983. PMID: 6366135 Clinical Trial.

3

Prognostic and therapeutic significance of pathological features of breast cancer.

Fisher ER. Fisher ER. NCI Monogr. 1986;(1):29-34. NCI Monogr. 1986. PMID: 3774014

4

Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.

Fisher B, Redmond CK, Wickerham DL, Rockette HE, Brown A, Allegra J, Bowman D, Plotkin D, Wolter J. Fisher B, et al. Breast Cancer Res Treat. 1983;3(4):355-64. doi: 10.1007/BF01807588. Breast Cancer Res Treat. 1983. PMID: 6365208 Clinical Trial.

5

Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.

Fisher B, Wickerham DL, Brown A, Redmond CK. Fisher B, et al. J Clin Oncol. 1983 Jun;1(6):349-58. doi: 10.1200/JCO.1983.1.6.349. J Clin Oncol. 1983. PMID: 6668505

6

The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

Redmond C, Fisher B, Wieand HS. Redmond C, et al. Cancer Treat Rep. 1983 Jun;67(6):519-26. Cancer Treat Rep. 1983. PMID: 6344993 Clinical Trial. No abstract available.

7

Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers.

Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher ER. Fisher B, et al. Cancer. 1981 Oct 15;48(8):1863-72. doi: 10.1002/1097-0142(19811015)48:8<1863::aid-cncr2820480825>3.0.co;2-u. Cancer. 1981. PMID: 7284980

8

Treatment of primary breast cancer with chemotherapy and tamoxifen.

Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Campbell T, Elias EG, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, Shibata H. Fisher B, et al. N Engl J Med. 1981 Jul 2;305(1):1-6. doi: 10.1056/NEJM198107023050101. N Engl J Med. 1981. PMID: 7015139 Clinical Trial.

9

Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure.

Fisher ER, Sass R, Fisher B. Fisher ER, et al. Cancer. 1984 Feb 1;53(3 Suppl):712-23. doi: 10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i. Cancer. 1984. PMID: 6692274

10

Tissue mast cells in breast cancer.

Fisher ER, Sass R, Watkins G, Johal J, Fisher B. Fisher ER, et al. Breast Cancer Res Treat. 1985;5(3):285-91. doi: 10.1007/BF01806023. Breast Cancer Res Treat. 1985. PMID: 4027395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year